Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
The enhancer for the immunoglobulin mu heavy chain gene (IgH) activates a heterologous gene at the pre-B cell stage of B lymphocyte differentiation. A lymphoid-specific element, microB, is necessary for enhancer function in pre-B cells. A microB binding protein is encoded by the PU.1/Spi-1 proto-oncogene. Another sequence element, microA, was identified in the mu enhancer that binds the product of the ets-1 proto-oncogene. The microA motif was required for microB-dependent enhancer activity, which suggests that a minimal B cell-specific enhancer is composed of both the PU.1 and Ets-1 binding sites. Co-expression of both PU.1 and Ets-1 in nonlymphoid cells trans-activated reporter plasmids that contained the minimal mu enhancer. These results implicate two members of the Ets family in the activation of IgH gene expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In case of the B-lymphoid genes such as Ig heavy chain (μ) [34], Ig light chains (κ and λ) [35, 36], mb- (Ig α) [37], B29 (Ig β) [38] and Ig-J chain [33], the binding of PU.1 to the enhancer regions induces the bending of DNA that facilitates the binding of other transcription factors to their respective binding sites, thus forming a synergistic multiprotein-complex to augment transcription.”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [34]
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90346-6 · Cited by 2,752
Self-citationThe c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
The myoD Gene Family: Nodal Point During Specification of the Muscle Cell Lineage
Weintraub, H., Davis, R., Tapscott, S., Thayer, M., Krause, M., Benezra, R., Blackwell, T. K., Turner, D., Rupp, R., Hollenberg, S., et al. (1991) · Science · doi:10.1126/science.1846704 · Cited by 1,572
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954
Self-citationLopata, M. A., Cleveland, D. W., & Sollner-Webb, B. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.14.5707 · Cited by 822
B Lineage—Specific Interactions of an Immunoglobulin Enhancer with Cellular Factors in Vivo
Ephrussi, A., Church, G. M., Tonegawa, S., & Gilbert, W. (1985) · Science · doi:10.1126/science.3917574 · Cited by 796
Developmentally controlled and tissue-specific expression of unrearranged VH gene segments
Yancopoulos, G. (1985) · Cell · doi:10.1016/0092-8674(85)90141-2 · Cited by 696
Protein-Binding Sites in Ig Gene Enhancers Determine Transcriptional Activity and Inducibility
Lenardo, M., Pierce, J. W., & Baltimore, D. (1987) · Science · doi:10.1126/science.3109035 · Cited by 578
The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence.
Karim, F. D., Urness, L. D., Thummel, C. S., Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., Maki, R. A., Gunther, C. V., & Nye, J. A. (1990) · Genes & Development · doi:10.1101/gad.4.9.1451 · Cited by 499
Self-citation
Cited by
Helix-Loop-Helix Proteins: Regulators of Transcription in Eucaryotic Organisms
Massari, M. E., & Murre, C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.429-440.2000 · Cited by 1,816
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
Structure and function of helix-loop-helix proteins
Murre, C., Bain, G., van Dijk, M. A., Engel, I., Furnari, B. A., Massari, M. E., Matthews, J. R., Quong, M. W., Rivera, R. R., & Stuiver, M. H. (1994) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(94)90001-9 · Cited by 511
Ets target genes: past, present and future
Sementchenko, V. I., & Watson, D. K. (2000) · Oncogene · doi:10.1038/sj.onc.1204034 · Cited by 371
“…l2-4 Enhancer J558L (myeloma) PU.1 AAAGGAAGTG m (Eisenbeis et al., 1993) Ig m heavy chain COS, NIH3T3 PU.1, ETS1 TGGGGAAGGG m,f (Erman and Sen, 1996; Nelsen et al., 1993; Rao et al., 1997; Rivera et al., 1993) p, PreBCell specific IgH HAFTL, PD31 EBS GCAGGAAGCA m (Libermann and Baltimore,…”
BackgroundSpecificity within the ets Family of Transcription Factors
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60738-1 · Cited by 344
Self-citationBories, J.-C., Willerford, D. M., Grévin, D., Davidson, L., Camus, A., Martin, P., Stéhelin, D., & Alt, F. W. (1995) · Nature · doi:10.1038/377635a0 · Cited by 317
Herrscher, R. F., Kaplan, M. H., Lelsz, D. L., Das, C., Scheuermann, R., & Tucker, P. W. (1995) · Genes & Development · doi:10.1101/gad.9.24.3067 · Cited by 267
Hahm, K., Ernst, P., Lo, K., Kim, G. S., Turck, C., & Smale, S. T. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7111 · Cited by 224
Multiple Functional Domains of AML1: PU.1 and C/EBPα Synergize with Different Regions of AML1
Petrovick, M. S., Hiebert, S. W., Friedman, A. D., Hetherington, C. J., Tenen, D. G., & Zhang, D.-E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3915 · Cited by 218
“mAML1A(1-288) is terminated at amino acid 288 of AML1A.”
BackgroundMethodInfluentialYang, C., Shapiro, L. H., Rivera, M., Kumar, A., & Brindle, P. K. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2218 · Cited by 213
“RSV CBP2 was constructed by inserting a HindIIIXbaI fragment containing mouse CBP sequences that lacked aa 739 to 2394 into the RSV expression vector pGR. Gal-Ets 2–440 was constructed by inserting a BamHI-SpeI fragment encoding mouse p54 Ets-1 aa 2 to 440 from pEVRFOEts1 into the Gal4 fusion vector pM2 cut with BamHI…”
MethodSpi-1/PU.1 Transgenic Mice Develop Multistep Erythroleukemias
Moreau-Gachelin, F., Wendling, F., Molina, T., Denis, N., Titeux, M., Grimber, G., Briand, P., Vainchenker, W., & Tavitian, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2453 · Cited by 189
The role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis
Burda, P., Laslo, P., & Stopka, T. (2010) · Leukemia · doi:10.1038/leu.2010.104 · Cited by 184
Factors and forces controlling V(D) J recombination
Hesslein, D. G. T., & Schatz, D. G. (2001) · Advances in immunology · doi:10.1016/s0065-2776(01)78004-2 · Cited by 183
An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors
Seidel, J. J., & Graves, B. J. (2002) · Genes & Development · doi:10.1101/gad.950902 · Cited by 182
“The mammalian expression plasmid pEVRFO-Ets-1 was described previously (Nelsen et al. 1993).”
MethodSelf-citationDefective B cell receptor‐mediated responses in mice lacking the Ets protein, Spi‐B
Su, G. H., Chen, H., Muthusamy, N., Garrett‐Sinha, L. A., Baunoch, D., Tenen, D. G., & Simon, M. C. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.7118 · Cited by 182
“Many genes which are important for B lymphoid and myeloid development have been identified as putative PU.1 target genes: Ig heavy chain (μ) (Nelsen et al., 1993), Ig light chains (κ and λ) (Pongubala et al., 1992; Eisenbeis et al., 1993), mb-1 (Igα) (Feldhaus et al., 1992; Hagman and Grosschedl,…”
BackgroundGenetta, T., Ruezinsky, D., & Kadesch, T. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.6153 · Cited by 181
“1, ETS-1 (25), Erg-3, and Fli-1 (28); and a zinc finger protein, YY-1 (27, 33).”
Accessibility Control of V(D)J Recombination
Cobb, R. M., Oestreich, K. J., Osipovich, O. A., & Oltz, E. M. (2006) · Advances in Immunology · doi:10.1016/s0065-2776(06)91002-5 · Cited by 160
ETS transcription factors and regulation of immunity
Gallant, S., & Gilkeson, G. (2006) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-006-0017-z · Cited by 163
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
Chang, H.-C., Zhang, S., Thieu, V. T., Slee, R. B., Bruns, H. A., Laribee, R. N., Klemsz, M. J., & Kaplan, M. H. (2005) · Immunity · doi:10.1016/j.immuni.2005.03.016 · Cited by 159
Fisher, R. C., & Scott, E. W. (1998) · STEM CELLS · doi:10.1002/stem.160025 · Cited by 158
The IgH Locus 3′ Regulatory Region
Pinaud, E., Marquet, M., Fiancette, R., Péron, S., Vincent‐Fabert, C., Denizot, Y., & Cogné, M. (2011) · Advances in immunology · doi:10.1016/b978-0-12-387663-8.00002-8 · Cited by 172
“Nelsen et al., 1993; 20.”
The transcription factor PU.1 is involved in macrophage proliferation.
Celada, A., Borràs, F. E., Soler, C., Lloberas, J., Klemsz, M., van Beveren, C., McKercher, S., & Maki, R. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.61 · Cited by 152
Self-citationCytoplasmic Sequestration of Rel Proteins by IκBα Requires CRM1-Dependent Nuclear Export
Tam, W. F., Lee, L. H., Davis, L., & Sen, R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.2269-2284.2000 · Cited by 151
“COS cell transfection was done by the calcium phosphate method as previously described (19).”
MethodSelf-citationSun, W., Graves, B. J., & Speck, N. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4941-4949.1995 · Cited by 149
Self-citationCharacterization of the Cooperative Function of Inhibitory Sequences in Ets-1
Jonsen, M. D., Petersen, J. M., Xu, Q.-P., & Graves, B. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2065 · Cited by 146
“1 on the immunoglobulin m-chain enhancer (34).”
Self-citationThe immunoglobulin genes of fish
Warr, G. W. (1995) · Developmental & Comparative Immunology · doi:10.1016/0145-305x(94)00052-h · Cited by 146
The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages
Lloberas, J., Soler, C., & Celada, A. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01442-5 · Cited by 142
TRANSCRIPTIONAL REGULATION DURING B CELL DEVELOPMENT
Henderson, A., & Calame, K. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.163 · Cited by 137
Laux, G., Adam, B.-L., Strobl, L. J., & Moreau-Gachelin, F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06900.x · Cited by 151
Ma, X., Neurath, M., Gri, G., & Trinchieri, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10389 · Cited by 138
Colucci, F., Samson, S. I., DeKoter, R. P., Lantz, O., Singh, H., & Di Santo, J. P. (2001) · Blood · doi:10.1182/blood.v97.9.2625 · Cited by 136
Fisher, R. J., Fivash, M., Casas‐Finet, J., Erickson, J. W., Kondoh, A., Bladen, S. V., Fisher, C., Watson, D. K., & Papas, T. (1994) · Protein Science · doi:10.1002/pro.5560030210 · Cited by 127
Torlakovic, E., Tierens, A. M., Dang, H. D., & Delabie, J. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63027-1 · Cited by 160
Fukuma, M., Okita, H., Hata, J.-I., & Umezawa, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206055 · Cited by 126
“The functional synergy between ets oncoproteins with other transcription factors such as AP-1, Sp-1, and c-myb has been reported (Wasylyk et al., 1990; Gegonne et al., 1993; Nelsen et al., 1993; Pankov et al., 1994).”
BackgroundPU.1 and Spi-B Are Required for Normal B Cell Receptor–Mediated Signal Transduction
Garrett‐Sinha, L. A., Su, G. H., Rao, S., Kabak, S., Hao, Z., Clark, M. R., & Simon, M. C. (1999) · Immunity · doi:10.1016/s1074-7613(00)80040-0 · Cited by 138
Wang, D., John, S. A., Clements, J. L., Percy, D. H., Barton, K. P., & Garrett-Sinha, L. A. (2005) · International Immunology · doi:10.1093/intimm/dxh295 · Cited by 119
“Indeed, Ets-1 has been reported to directly bind to the Ig heavy chain intronic enhancer and to contribute to the activity of this enhancer element ( 30 ).”
BackgroundCombinatorial regulation of transcription II: the immunoglobulin μ heavy chain gene
Ernst, P., & Smale, S. T. (1995) · Immunity · doi:10.1016/1074-7613(95)90024-1 · Cited by 132
Lopez, M., Oettgen, P., Akbarali, Y., Dendorfer, U., & Libermann, T. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.3292 · Cited by 120
Bradford, A. P., Conrad, K. E., Wasylyk, C., Wasylyk, B., & Gutierrez-Hartmann, A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2849 · Cited by 114
“By contrast, the vast majority of examples published to date show that an Ets member cooperates with another transcription factor only at the level of promoter activation, and they fail to provide biochemical evidence for any direct physical interactions (11, 17, 19, 22, 60, 61, 70, 83, 87).”
BackgroundThe Role of Ets Transcription Factors in the Development and Function of the Mammalian Immune System
Bassuk, A. G., & Leiden, J. M. (1997) · Advances in immunology · doi:10.1016/s0065-2776(08)60887-1 · Cited by 125
Jenuwein, T., Forrester, W. C., Qiu, R., & Grosschedl, R. (1993) · Genes & Development · doi:10.1101/gad.7.10.2016 · Cited by 117
Spi-1/PU.1: an oncogene of the Ets family
Moreau-Gachelin, F. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90011-6 · Cited by 110
Oikawa, T., Yamada, T., Kihara-Negishi, F., Yamamoto, H., Kondoh, N., Hitomi, Y., & Hashimoto, Y. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400534 · Cited by 109
“1 regulates the immunoglobulin genes.(26) A minimal domain of the intronic enhancer of the immunoglobulin m heavy-chain (IgH) gene is composed of the mA, mE3 and mB that bind Ets-1, TFE3/AML1 and PU.”
BackgroundBradford, A. P., Wasylyk, C., Wasylyk, B., & Gutierrez-Hartmann, A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1065 · Cited by 108
“Furthermore, Ets-1 mRNA is not detected by Northern analysis in HeLa cells (42).”
BackgroundKas, K., Finger, E., Grall, F., Gu, X., Akbarali, Y., Boltax, J., Weiss, A., Oettgen, P., Kapeller, R., & Libermann, T. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2986 · Cited by 109
Ets proteins: new factors that regulate immunoglobulin heavy-chain gene expression.
Rivera, R. R., Stuiver, M. H., Steenbergen, R., & Murre, C. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.11.7163 · Cited by 100
Fernández, L. A., Winkler, M., & Grosschedl, R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.1.196-208.2001 · Cited by 97
“same cell type specificity as the enhancer in combination with a MAR (32, 50, 53).”
BackgroundThe Transcription Factor PU.1 is a Critical Regulator of Cellular Communication in the Immune System
Turkistany, S. A., & DeKoter, R. P. (2011) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-011-0147-9 · Cited by 96
Jundt, F., Kley, K., Anagnostopoulos, I., Schulze Pröbsting, K., Greiner, A., Mathas, S., Scheidereit, C., Wirth, T., Stein, H., & Dörken, B. (2002) · Blood · doi:10.1182/blood.v99.8.3060 · Cited by 99
Neurath, M., Max, E. E., & Strober, W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5336 · Cited by 96
c-Maf Interacts with c-Myb To Regulate Transcription of an Early Myeloid Gene during Differentiation
Hegde, S. P., Kumar, A., Kurschner, C., & Shapiro, L. H. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2729 · Cited by 93
Activation of Transcription by PU.1 Requires both Acidic and Glutamine Domains
Klemsz, M. J., & Maki, R. A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.1.390 · Cited by 93
Self-citationLoddenkemper, C., Anagnostopoulos, I., Hummel, M., Jöhrens‐Leder, K., Foss, H., Jundt, F., Wirth, T., Dörken, B., & Stein, H. (2003) · The Journal of Pathology · doi:10.1002/path.1485 · Cited by 104
“1 [19] and is further supported by our finding that Eμ enhancer activity can be re-established by transduction of PU.”
BackgroundThe human beta 2 integrin CD18 promoter consists of two inverted Ets cis elements.
Böttinger, E. P., Shelley, C. S., Farokhzad, O. C., & Arnaout, M. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2604 · Cited by 89
Feinman, R., Qiu, W. Q., Pearse, R. N., Nikolajczyk, B. S., Sen, R., Sheffery, M., & Ravetch, J. V. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06696.x · Cited by 88
Self-citationYamada, T., Kondoh, N., Matsumoto, M., Yoshida, M., Maekawa, A., & Oikawa, T. (1997) · Blood · doi:10.1182/blood.v89.4.1383 · Cited by 87
Rosmarin, A. G., Caprio, D. G., Kirsch, D. G., Handa, H., & Simkevich, C. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23627 · Cited by 87
Khachigian, L. M., Fries, J., Benz, M. W., Bonthron, D. T., & Collins, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31695-2 · Cited by 92
Characterization of NERF, a Novel Transcription Factor Related to the Ets Factor ELF-1
Oettgen, P., Akbarali, Y., Boltax, J., Best, J., Kunsch, C., & Libermann, T. A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.5091 · Cited by 85
“Thus, many B- and T-cell-specific genes contain functionally relevant binding sites for ets factors, including immunoglobulin (Ig) heavy and light chains; lck; blk; lyn; terminal deoxynucleotidyltransferase (TdT); mb-1; B29; interleukin-2 (IL-2); IL-2 receptor a and b; CD3; CD4; and T-cell receptor a, b, and d (4, 20,…”
BackgroundAthanasiou, M., Clausen, P. A., Mavrothalassitis, G. J., Zhang, X. K., Watson, D. K., & Blair, D. G. (1996) · PubMed · Cited by 102
Perez, C., Coeffier, E., Moreau-Gachelin, F., Wietzerbin, J., & Benech, P. D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5023 · Cited by 84
“1/Spi-1 was also found to be involved in controlling the activity of the immunoglobulin K and ,u heavy-chain enhancers through its interaction with the B-cell-restricted factor, NF-EM5, and the ets-1 oncogene, respectively (25, 33).”
BackgroundNagel, S., Scherr, M., Kel, A. E., Hornischer, K., Crawford, G. E., Kaufmann, M., Meyer, C., Drexler, H. G., & MacLeod, R. A. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2615 · Cited by 83
Singh, H. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80053-7 · Cited by 88
Wang, Z., Goldstein, A. M., Zong, R.-T., Lin, D., Neufeld, E. J., Scheuermann, R. H., & Tucker, P. W. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.284 · Cited by 80
“Several of these factors can transactivate reporter gene constructs in transient transfection studies (33, 67, 84).”
BackgroundImmunoglobulin genes and their transcriptional control in teleosts
Hikima, J.-I., Jung, T. S., & Aoki, T. (2010) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2010.10.011 · Cited by 83
Van Lint, C., Ghysdael, J., Paras, P., Burny, A., & Verdin, E. (1994) · Journal of Virology · doi:10.1128/jvi.68.4.2632-2648.1994 · Cited by 78
“1/Spi-1 binding sites are present in a large number of B-lymphoid-, myeloid-, and erythroid cell-specific transcriptional elements, such as the enhancers of two SV40 variants (66), the promoter of the major histocompatibility complex class II gene I-AP (20), the mouse immunoglobulin K3' enhancer (67), the promoter of…”
BackgroundAn Intron Transcriptional Enhancer Element Regulates IL-4 Gene Locus Accessibility in Mast Cells
Hural, J., Kwan, M., Henkel, G., Hock, M. B., & Brown, M. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3239 · Cited by 83
“1, a factor whose expression is limited to B cells, macrophages, neutrophils, and mast cells (41, 71–73), can bind to plasmids containing them enhancer (71, 74).”
BackgroundGupta, P., Gurudutta, G. U., Saluja, D., & Tripathi, R. P. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00757.x · Cited by 74
“In case of the B-lymphoid genes such as Ig heavy chain ( ) [34], Ig light chains ( and ) [35, 36], mb- (Ig ) [37], B29 (Ig ) [38] and Ig-J chain [33], the binding of PU.”
BackgroundPU.1/Interferon Regulatory Factor Interactions; Mechanisms of Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2000) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:33:2:127 · Cited by 74
Rosen, G., Barks, J., Iademarco, M. F., Fisher, R. J., & Dean, D. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40731-9 · Cited by 77
Bottaro, A., Young, F., Chen, J., Serwe, M., Sablitzky, F., & Alt, F. W. (1998) · International Immunology · doi:10.1093/intimm/10.6.799 · Cited by 71
Cooper, W. J., Jones, A. C., Whitehead, R. F., & Zika, R. G. (2007) · Environmental Science & Technology · doi:10.1021/es062975a · Cited by 79
Kihara-Negishi, F., Yamamoto, H., Suzuki, M., Yamada, T., Sakurai, T., Tamura, T., & Oikawa, T. (2001) · Oncogene · doi:10.1038/sj.onc.1204756 · Cited by 69
“…expression is restricted to hematopoietic cells, predominantly the B cell and macrophage lineages, to modulate cell type-speci®c expression of genes such as the immunoglobulin (Ig) genes (Nelsen et al., 1993) and the macrophage colony-stimulating factor (M-CSF) receptor gene (Zhang et al., 1994).”
BackgroundWatts, P. C., Thorpe, J. P., & Taylor, P. D. (1998) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1998.0222 · Cited by 69
Hematopoietic lineage commitment: Role of transcription factors
Kehrl, J. H. (1995) · STEM CELLS · doi:10.1002/stem.5530130304 · Cited by 69
Himmelmann, A., Riva, A., Wilson, G. L., Lucas, B. P., Thevenin, C., & Kehrl, J. H. (1997) · Blood · doi:10.1182/blood.v90.10.3984 · Cited by 68
Review: The Role of IRF-4 in Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452737 · Cited by 67
“50– 55 The regulation of 69) Most important to this discussion, serine phosphorylation within the PEST domain, specifically serine 148, is required for activation of PU.1 in mature macrophages and for interaction with IRF-4.”
Genetic Mechanisms of Age Regulation of Human Blood Coagulation Factor IX
Kurachi, S., Deyashiki, Y., Takeshita, J., & Kurachi, K. (1999) · Science · doi:10.1126/science.285.5428.739 · Cited by 68
Nagulapalli, S., & Atchison, M. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.8.4639 · Cited by 66
Sikes, M. L., Gomez, R. J., Song, J., & Oltz, E. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.3.1399 · Cited by 72
Analysis of the Bruton's tyrosine kinase gene promoter reveals critical PU.1 and SP1 sites
Himmelmann, A., Thevenin, C., Harrison, K., & Kehrl, J. (1996) · Blood · doi:10.1182/blood.v87.3.1036.bloodjournal8731036 · Cited by 65
Gunther, C. V., & Graves, B. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7569 · Cited by 64
Self-citationETS-Core Binding Factor: a Common Composite Motif in Antigen Receptor Gene Enhancers
Erman, B., Cortes, M., Nikolajczyk, B. S., Speck, N. A., & Sen, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1322 · Cited by 62
“Indeed, the reduced activity was reminiscent of the mE3(2) mutation that abolished both CBFa2 and TFE3 binding (24).”
InfluentialSelf-citationBellon, T., Perrotti, D., & Calabretta, B. (1997) · Blood · doi:10.1182/blood.v90.5.1828 · Cited by 62
Fernex, C., Capone, M., & Ferrier, P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3217 · Cited by 61
“Additional elements important for lymphoid cell and/or pre-B-cell specificity include the octanucleotide motif which binds members of the POU domain family of transcription factors (reviewed in reference 50) and the p/mA and mB motifs which interact with members of the Ets protein family (40, 44, 48).”
Backgroundπ1 Binding Sites Are Negative Regulators of bcl-2 Expression in Pre-B Cells
Chen, H.-M., & Boxer, L. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3840 · Cited by 59
“1, ERG-3, and ERP, have been shown to bind in vitro (22, 26, 31).”
BackgroundOctamer Binding Factors and Their Coactivator Can Activate the Murine PU.1 (spi-1) Promoter
Chen, H.-M., Zhang, P., Radomska, H. S., Hetherington, C. J., Zhang, D.-E., & Tenen, D. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15743 · Cited by 59
Transcriptional Activation by ETS and Leucine Zipper-Containing Basic Helix-Loop-Helix Proteins
Tian, G., Erman, B., Ishii, H., Gangopadhyay, S. S., & Sen, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2946 · Cited by 56
“1 and Ets-1 are simultaneously present (17).”
BackgroundSelf-citationMultiple motifs regulate the B-cell-specific promoter of the B29 gene.
Omori, S. A., & Wall, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11723 · Cited by 60
Involvement of the Ets Family Factor PU.1 in the Activation of Immunoglobulin Promoters
Schwarzenbach, H., Newell, J. W., & Matthias, P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.898 · Cited by 57
A Potential Role for Elf-1 in Terminal Transferase Gene Regulation
Ernst, P., Hahm, K., Trinh, L., Davis, J. N., Roussel, M. F., Turck, C. W., & Smale, S. T. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6121 · Cited by 58
Regulation of gene expression at early stages of B-cell differentiation
Hagman, J. R., & Grosschedl, R. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90095-7 · Cited by 59
Gangenahalli, G. U., Gupta, P., Saluja, D., Verma, Y. K., Kishore, V., Chandra, R., Sharma, R. K., & Ravindranath, T. (2005) · Stem Cells and Development · doi:10.1089/scd.2005.14.140 · Cited by 53
Arguello, M., Sgarbanti, M., Hernandez, E., Mamane, Y., Sharma, S., Servant, M. J., Lin, R., & Hiscott, J. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206270 · Cited by 63
“…B cells, PU.1 is expressed at all stages of maturation (excluding plasma cells) and it regulates B-cell-specific genes including the m heavy chain (Nelsen et al., 1993; Rao et al., 1997), the Ig light chains (l and k) (Pongubala et al., 1992; Eisenbeis et al., 1993), Iga (Feldhaus et al., 1992),…”
BackgroundERM, a PEA3 Subfamily of Ets Transcription Factors, Can Cooperate with c-Jun
Nakae, K., Nakajima, K., Inazawa, J., Kitaoka, T., & Hirano, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23795 · Cited by 53
Eyquem, S., Chemin, K., Fasseu, M., Chopin, M., Sigaux, F., Cumano, A., & Bories, J. (2004) · European Journal of Immunology · doi:10.1002/eji.200425352 · Cited by 52
Inhibition of p300/CBP by Early B-Cell Factor
Zhao, F., McCarrick-Walmsley, R., Åkerblad, P., Sigvardsson, M., & Kadesch, T. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.11.3837-3846.2003 · Cited by 55
“The addition of purified GST-EBF also inhibited the reaction while GST alone had no effect (Fig.”
BackgroundInfluentialPU.1/Spi-B Regulation of c-rel Is Essential for Mature B Cell Survival
Hu, C., Rao, S., Ramírez‐Bergeron, D. L., Garrett‐Sinha, L. A., Gerondakis, S., Clark, M. R., & Simon, M. C. (2001) · Immunity · doi:10.1016/s1074-7613(01)00219-9 · Cited by 57
Spi-C, a Novel Ets Protein That Is Temporally Regulated during B Lymphocyte Development
Bemark, M., Mårtensson, A., Liberg, D., & Leanderson, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10259 · Cited by 53
ETS Protein–Dependent Accessibility Changes at the Immunoglobulin μ Heavy Chain Enhancer
Nikolajczyk, B. S., Sanchez, J. A., & Sen, R. (1999) · Immunity · doi:10.1016/s1074-7613(00)80077-1 · Cited by 51
Self-citation
Metadata
- Authors
- Nelsen, B., Tian, G., Erman, B., Gregoire, J., Maki, R., Graves, B., & Sen, R.
- Affiliations
- Brandeis University (US)
- University of Utah (US)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Venue
- Science
- Published
- 1993-07-02
- Volume
- 261
- Issue
- 5117
- Pages
- 82-86
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2041497115
- Cited by
- 222
- References
- 34
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2018: 1 · 2017: 5 · 2016: 1 · 2015: 1 · 2014: 3 · 2012: 3
- FWCI
- 9.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k04gm000563-03)
- National Institute of General Medical Sciences (GM 38663, GM-38925, 1K04GM00563)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- enhancer regulation, ETS transcription factors, ETS1, pre-B cell differentiation, B cell development, transcriptional activation
- MeSH terms
- Proto-Oncogene Mas, Animals, B-Lymphocytes, Base Sequence, Binding Sites, Cell Differentiation, Cell Line, DNA-Binding Proteins, Enhancer Elements, Genetic, Female, Genes, Immunoglobulin, Humans, Immunoglobulin mu-Chains, Molecular Sequence Data, Mutation, Proto-Oncogene Proteins, Transcription Factors, Retroviridae Proteins, Oncogenic, Proto-Oncogene Proteins c-ets, Proto-Oncogene Protein c-ets-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.